ERIN DUPREE: Open Payments
NPI 1881836658 · NORTH SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 19 payments from 9 companies in 2025. Trend: 2023 $48 · 2024 $668 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $123 |
| ABBVIE INC. | 5 | $106 |
| Boston Scientific Corporation | 1 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| PFIZER INC. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, Ozempic, WaveWriter Alpha Prime 16, CAPLYTA, Wegovy, Auvelity, OTEZLA, UBRELVY.
Industry payments across NY — which companies pay providers there.
